What Does Kintai Therapeutics Do?

Total employees45
HeadquartersCambridge
Founded2016

Kintai Therapeutics was a biotechnology company dedicated to pioneering precision enteric medicines by leveraging the body's enteric signaling network. Their research focused on understanding and modulating gut-brain and gut-immune axes to develop novel treatments for diseases in immunology, oncology, and neuroscience. Kintai aimed to create a new class of medicines by targeting the complex interactions within the gut. In November 2022, Kintai Therapeutics was acquired by Senda Biosciences, integrating its platform and talent into Senda's efforts to develop programmable medicines.

Where Is Kintai Therapeutics's Headquarters?

HQ Function

Served as the primary center for research and development, discovery science, corporate strategy, and administrative operations.

Notable Features:

Located within the vibrant Kendall Square ecosystem, providing proximity to leading academic institutions like MIT and Harvard, other biotech companies, and venture capital firms.

Work Culture:

As a Flagship Pioneering-founded biotech, the work culture was likely characterized by scientific rigor, innovation, collaboration, and a fast-paced environment focused on translational research.

HQ Significance:

The Cambridge location was strategically important for access to top scientific talent, cutting-edge research infrastructure, and a supportive network for biotech growth.

Values Reflected in HQ: The headquarters' location and setup likely reflected values of innovation, scientific excellence, and a commitment to advancing healthcare through novel therapeutic approaches.

Location:

Prior to its acquisition, Kintai Therapeutics' operations were primarily based in the United States, with its headquarters in Cambridge, MA, serving as its main hub for research and development. Any global activities would have likely involved research collaborations or considerations for future clinical trials. Post-acquisition, its legacy and assets are part of Senda Biosciences' broader global strategy.

Street Address:

215 First Street, Suite 210

City:

Cambridge

State/Province:

MA

Country:

USA

Where Else Does Kintai Therapeutics Operate Around the World?

No additional office locations available.

Buying Intent Signals for Kintai Therapeutics

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Kintai Therapeutics? Meet the Executive Team

As of April 2025, Kintai Therapeutics' leadership includes:

Paul-Peter Tak, MD, PhD, FMedSci - Former President and Chief Executive Officer
David Hava, PhD - Former Chief Scientific Officer
Jason Ferrone, MBA - Former Chief Financial Officer
Francesco Marincola, MD - Former Chief Scientific Officer (succeeded by David Hava)

Who's Investing in Kintai Therapeutics?

Kintai Therapeutics has been backed by several prominent investors over the years, including:

Flagship Pioneering (Founder and Primary Investor)
Alexandria Venture Investments
Humana

What Leadership Changes Has Kintai Therapeutics Seen Recently?

Hire0
Exits0

Kintai Therapeutics was acquired by Senda Biosciences in November 2022 and no longer operates as an independent entity. Therefore, there have been no executive hires or exits for Kintai Therapeutics in the last 12 months. Key leadership transitions occurred prior to or as part of the acquisition.

What Technology (Tech Stack) Is Used byKintai Therapeutics?

Discover the tools Kintai Therapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Kintai Therapeutics Email Formats and Examples

Prior to its acquisition, Kintai Therapeutics likely utilized standard corporate email formats based on its domain kintaitx.com. Common formats include first initial followed by last name, or first name followed by last name. These email addresses are no longer active.

[first_initial][last]@kintaitx.com

Format

jdoe@kintaitx.com

Example

0 (Company acquired, emails defunct; historically estimated 75-85)%

Success rate

What's the Latest News About Kintai Therapeutics?

PR NewswireNovember 15, 2022

Senda Biosciences Acquires Kintai Therapeutics to Further Strengthen Its Leadership Position in the Emerging Field of Programmable Medicines

Senda Biosciences announced it has acquired Kintai Therapeutics. The acquisition combines Kintai's pioneering work in precision enteric medicines and its talented team with Senda's proprietary platform and programs....more

Business WireOctober 8, 2019

Kintai Therapeutics Launches to Unlock the Power of the Enteric Signaling Network to Develop Novel Medicines

Kintai Therapeutics launched, after being founded within Flagship Labs, with a focus on the enteric signaling network and its role in health and disease. The company aimed to develop a new class of medicines for a broad range of diseases....more

FierceBiotechJanuary 7, 2020

Flagship's Kintai hires GSK's Paul-Peter Tak as CEO

Kintai Therapeutics appointed Paul-Peter Tak, M.D., Ph.D., as its president and CEO. Dr. Tak joined Kintai from GlaxoSmithKline, where he held several senior leadership roles....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Kintai Therapeutics, are just a search away.